Advertisement.

OMGA Projected Dividend Yield

Omega Therapeutics Inc ( NASDAQ : OMGA )

Omega Therapeutics is delveoping an approach to use mRNA therapeutics as programmable epigenetic medicines by utilizing its OMEGA Epigenomic Programming platform. Co. designs and engineers its mRNA therapeutics, which are programmable and modular epigenetic medicines, called Omega Epigenomic Controllers (OECs) to target EpiZips for Precision Genomic Control. Co.'s pipeline consists of early-stage, preclinical programs that span oncology, multigenic diseases. Co. has conducted in vivo preclinical studies of its OECs in multiple disease models for various indications, including hepatocellular carcinoma, non-small cell lung cancer, and acute respiratory distress syndrome.

21 YEAR PERFORMANCE RESULTS

OMGA Dividend History Detail
OMGA Dividend News
OMGA Competitors News

# of Shares: 0

Closing Price: 0.84

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
2026	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000